Search Browse Earnings

Equillium, Inc. — SlamSEC

Equillium, Inc.

Nasdaq:EQ

Pharmaceutical Preparations·LA JOLLA, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$36.1M

+129.0% YoY

FY 2024

Adj. EBITDA

-$14.4M

-40.0% margin

FY 2024

Net Income

-$13.3M

-37.0% margin

FY 2024

EPS (Diluted)

-$0.38

FY 2024

Stock Price

$1.95

+10.3%

2026-03-10

52W Range

$0.27 – $2.35

P/E Ratio

-5.1x

Market Cap

$118.7M

Cash

$23.2M

FY 2024

Total Debt

$9.0M

FY 2022

Net Cash

$14.3M

FY 2022

Enterprise Value

$104.5M

Debt / EBITDA

1.0x

FY 2024

EV / EBITDA

-7.2x

Employees

—